Literature DB >> 16616135

Framework for gender differences in human and animal toxicology.

Michael Gochfeld1.   

Abstract

Differences in exposure, anatomy, physiology, biochemistry, and behavior between males and females are a dominant theme in biology, transcending the plant and animal kingdoms. Yet differences due to sex and gender have not received adequate attention in human or animal toxicology nor always in epidemiology. Generalizations are often made about species' responses to xenobiotics, without data or consideration of female/male differences. Despite the leading role that pharmacology and drug development play in elucidating toxicokinetics, gender studies are relatively recent. Phenomenologic or clinical observations of sex differences often go unexplored, but pharmaceutical companies recognize the importance of enhanced understanding of toxicokinetics and toxicodynamics and emphasize the value of translational or integrational research--bringing laboratory findings to bedside applications and bedside questions to laboratory study. However, for many years Food and Drug Administration guidelines specifically precluded participation of females in many drug studies. Many occupational epidemiology studies, on which much of our understanding of toxic effects is based, begin by excluding women and minorities. Sex differentiation begins in the embryo under genetic and hormonal control. Changes affecting exposure, susceptibility, risk, and health continue throughout life. This paper provides a framework for analyzing the level(s) at which gender differences arise. The framework addresses exposure, toxicokinetics, toxicodynamics, and modulating influences. Men and women differ in many aspects of vulnerability to xenobiotics and other stressors, beginning with their opportunities for exposure. Toxicokinetic differences mainly involve metabolism, with few differences in absorption yet demonstrated. In addition, lifestyle, psychosocial, and hormonal factors modify the kinetics and responsiveness. Some phenomena fit the Classic Sex Hormone Paradigm in which castration (with and without hormone replacement) and administration of the opposite sex hormone demonstrate the primary regulatory role of sex hormones. Many phenomena, however, differ between males and females without showing a clear-cut relationship with the sex hormones. Since every cell both has a sex chromosome (X or Y) and is exposed to hormones, elegant techniques are just beginning to tease apart genetic from hormonal influences. Wherever possible, studies should use balanced gender and gender x age designs and should analyze data by sex and interactions, rather than simply adjusting for (discarding) gender. Power should be adequate, or lack of power (if inevitable) should be clearly stated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616135     DOI: 10.1016/j.envres.2005.12.005

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  33 in total

Review 1.  Same sex, no sex, and unaware sex in neurotoxicology.

Authors:  Bernard Weiss
Journal:  Neurotoxicology       Date:  2010-09-25       Impact factor: 4.294

2.  Genetic polymorphisms of GRIN2A and GRIN2B modify the neurobehavioral effects of low-level lead exposure in children.

Authors:  James P K Rooney; Nancy F Woods; Michael D Martin; James S Woods
Journal:  Environ Res       Date:  2018-04-11       Impact factor: 6.498

Review 3.  Sex Differences in Human and Animal Toxicology.

Authors:  Michael Gochfeld
Journal:  Toxicol Pathol       Date:  2016-11-28       Impact factor: 1.902

Review 4.  Biomarkers of susceptibility: State of the art and implications for occupational exposure to engineered nanomaterials.

Authors:  Ivo Iavicoli; Veruscka Leso; Paul A Schulte
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-24       Impact factor: 4.219

5.  Effects of obesity and sex on antimicrobial pharmacokinetics and acute kidney injury: validation of a preclinical model.

Authors:  Manjunath P Pai; Wen Zhen Chen; Adinoyi Garba; Huadong Cui; Barbara Zaffo; Hassan A N El-Fawal; Shaker A Mousa
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

Review 6.  Gender aspects in cardiovascular pharmacology.

Authors:  Sabine Oertelt-Prigione; Vera Regitz-Zagrosek
Journal:  J Cardiovasc Transl Res       Date:  2009-06-12       Impact factor: 4.132

7.  Modification of neurobehavioral effects of mercury by genetic polymorphisms of metallothionein in children.

Authors:  James S Woods; Nicholas J Heyer; Joan E Russo; Michael D Martin; Pradeep B Pillai; Federico M Farin
Journal:  Neurotoxicol Teratol       Date:  2013-07-01       Impact factor: 3.763

Review 8.  Sex-Specific Neurotoxic Effects of Organophosphate Pesticides Across the Life Course.

Authors:  Nicole Comfort; Diane B Re
Journal:  Curr Environ Health Rep       Date:  2017-12

9.  Modification of neurobehavioral effects of mercury by a genetic polymorphism of coproporphyrinogen oxidase in children.

Authors:  James S Woods; Nicholas J Heyer; Diana Echeverria; Joan E Russo; Michael D Martin; Mario F Bernardo; Henrique S Luis; Lurdes Vaz; Federico M Farin
Journal:  Neurotoxicol Teratol       Date:  2012-07-02       Impact factor: 3.763

10.  Is there a gender-related susceptibility for cisplatin ototoxicity?

Authors:  Günay Kirkim; Yüksel Olgun; Safiye Aktas; Müge Kiray; Efsun Kolatan; Zekiye Altun; Pınar Erçetin; Alper Bagriyanik; Osman Yilmaz; Hülya Ellidokuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-12       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.